G01N 2800/301
Anxiety or phobic disorders
G01N2800/301 (Anxiety or phobic disorders) appears on 28 US grants and 78 published applications in this corpus.
Search patents in G01N- Granted patents
- 28
- Published applications
- 78
- Assignees
- 63
- Inventors
- 184
- Latest grant
- 6 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 4 |
| 2004 | 1 | 3 |
| 2005 | 0 | 0 |
| 2006 | 1 | 3 |
| 2007 | 0 | 7 |
| 2008 | 0 | 2 |
| 2009 | 3 | 3 |
| 2010 | 0 | 5 |
| 2011 | 0 | 0 |
| 2012 | 2 | 5 |
| 2013 | 0 | 1 |
| 2014 | 1 | 3 |
| 2015 | 2 | 11 |
| 2016 | 2 | 5 |
| 2017 | 1 | 4 |
| 2018 | 4 | 4 |
| 2019 | 2 | 7 |
| 2020 | 2 | 1 |
| 2021 | 2 | 2 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 3 |
| 2025 | 1 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- DNA methylation and genotype specific biomarker for predicting post-traumatic stress disorder6 May 2025US 12,291,749 B2The Johns Hopkins University
- Basal ganglia-on-chip for screening therapeutic agents for brain and nervous system diseases16 Apr 2024US 11,959,909 B2Sogang University Research Foundation
- Application of PDCD4 as a therapeutic target for antidepressants and/or anxiolytics drugs3 May 2022US 11,320,440 B2Shandong University
- DNA methylation and genotype specific biomarker for predicting post-traumatic stress disorder27 Jul 2021US 11,072,828 B2The Johns Hopkins University
- Calcium binding protein, spermatid specific 1, as a biomarker for diagnosis or treatment of stress9 Mar 2021US 10,942,174 B2The Governors of the University of Alberta
- Inhibition of zbtb7a30 Jul 2026US 2026/0216225 A1Icahn School of Medicine at Mount Sinai
- Biomarker for diagnosis of anxiety disorders and use thereof30 Jul 2026US 2026/0218300 A1Cha University Industry-Academic Cooperation Foundation
- Dna methylation and genotype specific biomarker for predicting post-traumatic stress disorder11 Dec 2025US 2025/0376730 A1The Johns Hopkins University
- Bile acid metabolites for diagnosing and treating depressive disorders6 Jun 2024US 2024/0183845 A1
- Test for mild cognitive impairment2 May 2024US 2024/0142471 A1Osaka University
Most cited
By later US patents
- Diagnostic and therapeutic methods and products related to anxiety disorders10US 9,939,449 B2University of Vermont and State Agricultural College · 2018
- Diagnostic and therapeutic methods and products related to anxiety disorders8US 10,228,378 B2Emory University · 2019
- Methods for treating chronic obstructive pulmonary disease8US 8,877,773 B2Indiana University Research and Technology Corporation · 2014
- Method of treating depression7US 8,153,127 B2Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V. · 2012
- Method of identifying persons susceptible to autoimmune neuropsychiatric disorders2US 5,866,347 AThe United States of America as represented by the Department of Health and Human Services · 1999